Valuation: Shamrock Industrial Company Limited

Market Cap 15Cr 15.41L 13.6L 12.86L 11.67L 21.87L 22.09L 1.54Cr 59.48L 7.55Cr 57.85L 56.59L 24Cr P/E 2025
-53.4x
P/E 2026 -10.7x
Enterprise Value 15Cr 16.08L 14.19L 13.43L 12.18L 22.83L 23.06L 1.61Cr 62.09L 7.88Cr 60.39L 59.08L 25Cr EV / Sales 2025
-
EV / Sales 2026 609x
Free-Float
48.09%
Yield 2025 *
-
Yield 2026 -
14/08 Shamrock Industrial Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
29/05 Shamrock Industrial Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
12/02 Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
22/12 Shamrock Industrial Company Limited Approves the Proposals for Incorporation of Wholly Owned Subsidiaries CI
22/12 Shamrock Industrial Company Limited Approves the Proposals for Incorporation of Wholly Owned Subsidiaries CI
11/12 Shamrock Industrial Company Limited Announces Incorporation of Wholly Owned Subsidiary HODL Energy Private Limited in India CI
14/11 Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
13/11 Lotus Excel Wealth Creators LLP, HODL Systems LLP, Bagepalli Vijaykumar Harish and Rattan Kapoor completed the acquisition of 0.38% stake in Shamrock Industrial Company Limited for INR 0.34 million. CI
28/25/28 Shamrock Industrial appoints Rahul Manoj Rajani as chief financial officer RE
28/25/28 Shamrock Industrial Company Limited Approves Appointment of Rahul Manoj Rajani as Chief Financial Officer, Effective October 28, 2025 CI
28/25/28 Shamrock Industrial Company Limited Announces Board Appointments, Effective October 28, 2025 CI
16/25/16 Shamrock Industrial Company Limited Announces Resignation of Jitesh Rameshchandra Khokhani as Chief Financial Officer, with Effect from Closure of Business Hours of October 16, 2025 CI
16/25/16 Shamrock Industrial Company Limited Announces Board Resignations, with Effect from October 16, 2025 CI
Current month+4.97%
1 month+4.97%
3 months+15.66%
6 months+27.46%
Current year+40.46%
1 week 27.25
Extreme 27.25
27.25
1 month 25.96
Extreme 25.96
27.25
Current year 19.4
Extreme 19.4
27.25
1 year 17.6
Extreme 17.6
27.25
3 years 3.75
Extreme 3.75
27.25
5 years 3.16
Extreme 3.16
27.25
10 years 3.16
Extreme 3.16
27.25
Manager TitleAgeSince
Chief Executive Officer - 16/10/2025
Director of Finance/CFO - 28/10/2025
Compliance Officer - 30/01/2025
Director TitleAgeSince
Director/Board Member - 22/06/2021
Director/Board Member - 21/04/2022
Director/Board Member - 16/10/2025
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+54.83%+519.32% 15.41L
-0.01%+1.24%+63.06%+120.55% 1,05600Cr
-1.61%-0.60%+47.32%+71.79% 64TCr
-1.12%-0.72%+17.98%+76.63% 47TCr
+0.19%-3.58%+34.74%+41.18% 34TCr
+0.17%+3.08%+21.07%+29.83% 28TCr
-0.84%-0.64%+10.45%+12.79% 25TCr
+1.32%+3.27%+54.63%+57.63% 23TCr
-0.61%-0.91%+34.33%+101.87% 19TCr
-0.76%-0.95%-27.51%-60.76% 17TCr
Average +0.02%-0.11%+31.09%+97.08% 36.16TCr
Weighted average by Cap. +0.09%+0.24%+38.68%+70.95%

Financials

2025 2026
Net sales - 2L 2.09T 1.85T 1.75T 1.59T 2.97T 3T 20.98T 8.09T 1L 7.87T 7.69T 3L
Net income -12.6L -13.13T -11.59T -10.96T -9.94T -18.64T -18.83T -1L -50.69T -6L -49.31T -48.23T -20.71L -1.09Cr -1L -99.93T -94.55T -85.75T -2L -2L -11.34L -4L -55.49L -4L -4L -1.79Cr
Net Debt -1L -1.43T -1.26T -1.19T -1.08T -2.03T -2.05T -14.3T -5.51T -69.96T -5.36T -5.24T -2L 64.94L 67.68T 59.72T 56.51T 51.25T 96.08T 97.03T 7L 3L 33.16L 3L 2L 1.07Cr
Logo Shamrock Industrial Company Limited
Shamrock Industrial Company Limited is an India-based pharmaceuticals company. The Company offers a diverse range of manufacturing of pharmaceuticals and drugs products and allied business activities. It offers its products for various therapeutic uses, including anti-coagulants (anti-platelet), radio-protective agents, platelet regulator, anti-depressants, anti-neo plastics and immunosuppressants, antihistamines, sympathomimetics, anti-hypertensives, diuretic, anti-diabetic, calcium regulating agents, local anesthetics and anti-bacterial. Its active pharmaceutical ingredient (API) product list (manufactured) includes acenocomarol, amifostine, ciclopirox, cilazapril, losartan potassium, metaxalone, metoprolol succinate and pregabalin. The Company's API product list (contract manufactured) includes abacavir, acarbose, oxaliplatin, oxaprozin, finasteride, frusemide and colchicine.
Employees
1
Date Price Change Volume
28/26/28 ₹27.25 0.00% 1,520
  1. Stock Market
  2. Stocks
  3. SHAMROIN Stock